Id |
Subject |
Object |
Predicate |
Lexical cue |
T622 |
0-4 |
PR:000001393 |
denotes |
IL-6 |
T623 |
25-28 |
PR:000029150 |
denotes |
HLA |
T624 |
32-42 |
GO:0010467 |
denotes |
expression |
T85811 |
36-46 |
CL:0000542 |
denotes |
ession (Oh |
T68230 |
91-95 |
PR:000001889 |
denotes |
hat |
T625 |
95-99 |
PR:000001393 |
denotes |
IL-6 |
T60106 |
96-105 |
CL:0000576 |
denotes |
L-6 over- |
T626 |
133-136 |
PR:000029150 |
denotes |
HLA |
T627 |
140-150 |
GO:0010467 |
denotes |
expression |
T628 |
154-158 |
PR:000001889 |
denotes |
CD14 |
T629 |
159-168 |
CL:0000576 |
denotes |
monocytes |
T630 |
172-180 |
SP_7 |
denotes |
COVID-19 |
T13292 |
231-235 |
PR:000001889 |
denotes |
tion |
T11012 |
236-245 |
CL:0000576 |
denotes |
was found |
T631 |
254-259 |
UBERON:0001977 |
denotes |
serum |
T632 |
271-275 |
PR:000001393 |
denotes |
IL-6 |
T49571 |
275-285 |
SP_7 |
denotes |
and the a |
T633 |
303-306 |
PR:000029150 |
denotes |
HLA |
T634 |
310-319 |
CHEBI:36357;CHEBI:36357 |
denotes |
molecules |
T97052 |
314-319 |
UBERON:0002405 |
denotes |
cules |
T635 |
323-327 |
PR:000001889 |
denotes |
CD14 |
T636 |
328-337 |
CL:0000576 |
denotes |
monocytes |
T637 |
355-363 |
SP_7 |
denotes |
COVID-19 |
T23159 |
370-376 |
UBERON:0001969 |
denotes |
so bet |
T638 |
394-404 |
CL:0000542 |
denotes |
lymphocyte |
T53762 |
396-399 |
GO:0005675 |
denotes |
mph |
T20512 |
403-406 |
PR:000029150 |
denotes |
e c |
T92341 |
413-417 |
PR:000001889 |
denotes |
d th |
T57097 |
418-427 |
CL:0000576 |
denotes |
absolute |
T639 |
449-453 |
PR:000001889 |
denotes |
CD14 |
T640 |
454-463 |
CL:0000576 |
denotes |
monocytes |
T5836 |
458-468 |
SP_7 |
denotes |
cytes of p |
T641 |
481-489 |
SP_7 |
denotes |
COVID-19 |
T43055 |
496-501 |
UBERON:0002405 |
denotes |
es 5A |
T642 |
549-555 |
UBERON:0002405 |
denotes |
immune |
T28001 |
553-559 |
UBERON:0001969 |
denotes |
ne dys |
T643 |
556-569 |
GO:0065007 |
denotes |
dysregulation |
T97385 |
609-613 |
PR:000001889 |
denotes |
of |
T644 |
613-619 |
UBERON:0001969 |
denotes |
plasma |
T17918 |
614-623 |
CL:0000576 |
denotes |
lasma of |
T645 |
627-635 |
SP_7 |
denotes |
COVID-19 |
T52431 |
654-664 |
SP_7 |
denotes |
s already |
T50648 |
670-675 |
UBERON:0002405 |
denotes |
to be |
T22029 |
676-689 |
GO:0065007 |
denotes |
rich in IL-6. |
T646 |
684-688 |
PR:000001393 |
denotes |
IL-6 |
T647 |
694-704 |
GO:0010467 |
denotes |
expression |
T648 |
708-711 |
PR:000029150 |
denotes |
HLA |
T649 |
718-722 |
PR:000001889 |
denotes |
CD14 |
T650 |
723-732 |
CL:0000576 |
denotes |
monocytes |
T78000 |
729-735 |
UBERON:0001969 |
denotes |
tes wa |
T62942 |
737-747 |
GO:0065007 |
denotes |
strongly i |
T651 |
759-767 |
SP_7 |
denotes |
COVID-19 |
T652 |
768-774 |
UBERON:0001969 |
denotes |
plasma |
T73958 |
780-784 |
PR:000001393 |
denotes |
pati |
T4451 |
793-805 |
DG_35 |
denotes |
immune dysr |
T653 |
794-800 |
UBERON:0002405 |
denotes |
immune |
T654 |
801-814 |
GO:0065007 |
denotes |
dysregulation |
T655 |
826-832 |
UBERON:0001969 |
denotes |
plasma |
T60524 |
846-849 |
PR:000029150 |
denotes |
wi |
T50596 |
856-860 |
PR:000001889 |
denotes |
nter |
T33458 |
861-870 |
CL:0000576 |
denotes |
ediate im |
T656 |
868-874 |
UBERON:0002405 |
denotes |
immune |
T7540 |
902-912 |
SP_7 |
denotes |
s 5C–5F); |
T18315 |
918-923 |
UBERON:0002405 |
denotes |
ditio |
T79191 |
924-937 |
GO:0065007 |
denotes |
of the speci |
T657 |
956-960 |
PR:000001393 |
denotes |
IL-6 |
T658 |
969-980 |
DG_35 |
denotes |
Tocilizumab |
T30207 |
977-983 |
UBERON:0001969 |
denotes |
mab pa |
T4094 |
985-995 |
GO:0065007 |
denotes |
ially rest |
T659 |
1004-1014 |
GO:0010467 |
denotes |
expression |
T660 |
1018-1021 |
PR:000029150 |
denotes |
HLA |
T92474 |
1028-1032 |
PR:000001393 |
denotes |
mono |
T661 |
1028-1037 |
CL:0000576 |
denotes |
monocytes |
T42158 |
1041-1052 |
DG_35 |
denotes |
all patient |
T662 |
1059-1065 |
UBERON:0002405 |
denotes |
immune |
T663 |
1066-1079 |
GO:0065007 |
denotes |
dysregulation |
T95633 |
1096-1106 |
CL:0000542 |
denotes |
5F). Treat |
T664 |
1116-1127 |
DG_35 |
denotes |
Tocilizumab |
T72916 |
1170-1181 |
DG_35 |
denotes |
e of the ab |
T6130 |
1186-1199 |
GO:0005622 |
denotes |
e lymphocyte |
T665 |
1188-1198 |
CL:0000542 |
denotes |
lymphocyte |
T666 |
1199-1204 |
UBERON:0000178 |
denotes |
blood |
T53352 |
1213-1217 |
PR:000001393 |
denotes |
thin |
T7867 |
1221-1225 |
PR:000001889 |
denotes |
fir |
T62244 |
1226-1235 |
CL:0000576 |
denotes |
t 24 h (F |
T85042 |
1243-1246 |
PR:000001004 |
denotes |
). |
T667 |
1246-1250 |
PR:000001393 |
denotes |
IL-6 |
T55883 |
1247-1258 |
CL:0000542 |
denotes |
L-6 was pro |
T668 |
1274-1278 |
PR:000001889 |
denotes |
CD14 |
T669 |
1279-1288 |
CL:0000576 |
denotes |
monocytes |
T63178 |
1289-1299 |
SP_7 |
denotes |
and partly |
T670 |
1303-1306 |
PR:000001004 |
denotes |
CD4 |
T12355 |
1305-1310 |
UBERON:0002405 |
denotes |
4 cel |
T32432 |
1311-1324 |
GO:0065007 |
denotes |
s (Figure 5H) |
T671 |
1342-1355 |
GO:0065007 |
denotes |
Dysregulation |
T672 |
1366-1376 |
SP_7 |
denotes |
SARS-CoV-2 |
T673 |
1392-1396 |
PR:000001393 |
denotes |
IL-6 |
T674 |
1430-1435 |
UBERON:0001977 |
denotes |
serum |
T675 |
1447-1451 |
PR:000001393 |
denotes |
IL-6 |
T723 |
1462-1473 |
SP_7 |
denotes |
solute numb |
T724 |
1489-1493 |
PR:000001393 |
denotes |
DR o |
T676 |
1495-1499 |
PR:000001889 |
denotes |
CD14 |
T677 |
1500-1509 |
CL:0000576 |
denotes |
monocytes |
T725 |
1527-1532 |
UBERON:0001977 |
denotes |
rs) c |
T726 |
1544-1548 |
PR:000001393 |
denotes |
of c |
T727 |
1591-1595 |
PR:000001889 |
denotes |
rovi |
T728 |
1596-1605 |
CL:0000576 |
denotes |
ed.
(B) C |
T678 |
1637-1647 |
CL:0000542 |
denotes |
lymphocyte |
T679 |
1693-1697 |
PR:000001889 |
denotes |
CD14 |
T680 |
1698-1707 |
CL:0000576 |
denotes |
monocytes |
T729 |
1734-1744 |
CL:0000542 |
denotes |
rrelation |
T730 |
1789-1793 |
PR:000001889 |
denotes |
Chan |
T731 |
1794-1803 |
CL:0000576 |
denotes |
es of the |
T681 |
1835-1839 |
PR:000001889 |
denotes |
CD14 |
T682 |
1840-1849 |
CL:0000576 |
denotes |
monocytes |
T683 |
1879-1889 |
SP_7 |
denotes |
SARS-CoV-2 |
T684 |
1917-1923 |
UBERON:0002405 |
denotes |
immune |
T732 |
1932-1936 |
PR:000001889 |
denotes |
on a |
T733 |
1937-1946 |
CL:0000576 |
denotes |
ter incub |
T685 |
1974-1980 |
UBERON:0001969 |
denotes |
plasma |
T734 |
1976-1986 |
SP_7 |
denotes |
asma.
(D) |
T686 |
2001-2004 |
GO:0005675 |
denotes |
MFI |
T687 |
2008-2011 |
PR:000029150 |
denotes |
HLA |
T735 |
2014-2019 |
UBERON:0002405 |
denotes |
on C |
T688 |
2018-2022 |
PR:000001889 |
denotes |
CD14 |
T689 |
2023-2032 |
CL:0000576 |
denotes |
monocytes |
T690 |
2062-2072 |
SP_7 |
denotes |
SARS-CoV-2 |
T736 |
2070-2076 |
UBERON:0001969 |
denotes |
-2 wit |
T737 |
2097-2100 |
GO:0005675 |
denotes |
of |
T691 |
2100-2106 |
UBERON:0002405 |
denotes |
immune |
T738 |
2105-2108 |
PR:000029150 |
denotes |
e a |
T739 |
2115-2119 |
PR:000001889 |
denotes |
on a |
T740 |
2120-2129 |
CL:0000576 |
denotes |
ter incub |
T692 |
2157-2163 |
UBERON:0001969 |
denotes |
plasma |
T741 |
2159-2169 |
SP_7 |
denotes |
asma.
(E) |
T742 |
2198-2203 |
UBERON:0002405 |
denotes |
rs of |
T693 |
2215-2219 |
PR:000001889 |
denotes |
CD14 |
T694 |
2220-2229 |
CL:0000576 |
denotes |
monocytes |
T743 |
2254-2260 |
UBERON:0001969 |
denotes |
ed by |
T695 |
2260-2270 |
SP_7 |
denotes |
SARS-CoV-2 |
T696 |
2276-2282 |
UBERON:0002405 |
denotes |
immune |
T697 |
2283-2296 |
GO:0065007 |
denotes |
dysregulation |
T744 |
2312-2316 |
PR:000001889 |
denotes |
n wi |
T745 |
2317-2326 |
CL:0000576 |
denotes |
h medium |
T698 |
2336-2342 |
UBERON:0001969 |
denotes |
plasma |
T699 |
2344-2354 |
GO:0065007 |
denotes |
modulation |
T746 |
2357-2367 |
SP_7 |
denotes |
the addit |
T747 |
2373-2378 |
UBERON:0002405 |
denotes |
the |
T748 |
2379-2392 |
GO:0065007 |
denotes |
pecific IL-6 |
T700 |
2387-2391 |
PR:000001393 |
denotes |
IL-6 |
T701 |
2400-2411 |
DG_35 |
denotes |
Tocilizumab |
T749 |
2432-2438 |
UBERON:0001969 |
denotes |
hanges |
T750 |
2440-2450 |
GO:0065007 |
denotes |
f the MFI |
T702 |
2453-2456 |
PR:000029150 |
denotes |
HLA |
T703 |
2463-2467 |
PR:000001889 |
denotes |
CD14 |
T704 |
2468-2477 |
CL:0000576 |
denotes |
monocytes |
T751 |
2483-2487 |
PR:000001393 |
denotes |
ght |
T752 |
2496-2507 |
DG_35 |
denotes |
infected by |
T705 |
2508-2518 |
SP_7 |
denotes |
SARS-CoV-2 |
T706 |
2524-2530 |
UBERON:0002405 |
denotes |
immune |
T707 |
2531-2544 |
GO:0065007 |
denotes |
dysregulation |
T753 |
2550-2553 |
PR:000029150 |
denotes |
in |
T754 |
2560-2564 |
PR:000001889 |
denotes |
n wi |
T755 |
2565-2574 |
CL:0000576 |
denotes |
h medium |
T708 |
2584-2590 |
UBERON:0001969 |
denotes |
plasma |
T709 |
2592-2602 |
GO:0065007 |
denotes |
modulation |
T756 |
2605-2615 |
SP_7 |
denotes |
the addit |
T757 |
2621-2626 |
UBERON:0002405 |
denotes |
the |
T758 |
2627-2640 |
GO:0065007 |
denotes |
pecific IL-6 |
T710 |
2635-2639 |
PR:000001393 |
denotes |
IL-6 |
T711 |
2648-2659 |
DG_35 |
denotes |
tocilizumab |
T759 |
2680-2686 |
UBERON:0001969 |
denotes |
hanges |
T760 |
2688-2698 |
GO:0065007 |
denotes |
f the abso |
T712 |
2703-2713 |
CL:0000542 |
denotes |
lymphocyte |
T761 |
2731-2735 |
PR:000001393 |
denotes |
ents |
T762 |
2744-2755 |
DG_35 |
denotes |
nd after st |
T713 |
2777-2788 |
DG_35 |
denotes |
Tocilizumab |
T714 |
2794-2807 |
GO:0005622 |
denotes |
Intracellular |
T763 |
2799-2809 |
CL:0000542 |
denotes |
cellular s |
T715 |
2821-2825 |
PR:000001393 |
denotes |
IL-6 |
T716 |
2829-2833 |
PR:000001889 |
denotes |
CD14 |
T717 |
2834-2843 |
CL:0000576 |
denotes |
monocytes |
T718 |
2851-2854 |
PR:000001004 |
denotes |
CD4 |
T719 |
2855-2866 |
CL:0000542 |
denotes |
lymphocytes |
T764 |
2873-2884 |
DG_35 |
denotes |
ee patients |
T765 |
2890-2903 |
GO:0005622 |
denotes |
ted by SARS-C |
T720 |
2897-2907 |
SP_7 |
denotes |
SARS-CoV-2 |
T721 |
2913-2919 |
UBERON:0002405 |
denotes |
immune |
T766 |
2918-2922 |
PR:000001393 |
denotes |
e dy |
T722 |
2920-2933 |
GO:0065007 |
denotes |
dysregulation |
T767 |
2926-2930 |
PR:000001889 |
denotes |
ulat |
T768 |
2931-2940 |
CL:0000576 |
denotes |
on.
Stati |
T769 |
2948-2951 |
PR:000001004 |
denotes |
omp |
T770 |
2952-2963 |
CL:0000542 |
denotes |
risons are |
T771 |
2994-3004 |
SP_7 |
denotes |
n-signific |
T772 |
3010-3015 |
UBERON:0002405 |
denotes |
p < 0 |
T773 |
3016-3029 |
GO:0065007 |
denotes |
05; ∗∗p < 0.0 |